Algo version: 0.98b
Bausch + Lomb Corporation is listed at the NYSE Exchange
Bausch + Lomb Corporation [BLCO]
NYSE Sector: Healthcare Industry:Medical - Instruments & Supplies

Is Bausch + Lomb Corporation stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Bausch + Lomb Corporation 10 years ago, but if you had invested on Friday 6th of May 2022 when the price was $20.00, you would have made a loss of $-4.09 per share or -20.45%

Yes, the average daily trading liquidity for Bausch + Lomb Corporation is $578 716 thousand. You should therefore be able to get in and out of your positions relatively fast.

Bausch + Lomb Corporation has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.02, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Bausch + Lomb Corporation to be high [0.75 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.